TelyRx Holdings Inc.
TELY.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | 188.21% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 188.21% | -- | -- | -- | |
| Cost of Revenue | 142.74% | -- | -- | -- | |
| Gross Profit | 233.28% | -- | -- | -- | |
| SG&A Expenses | 284.52% | -- | -- | -- | |
| Depreciation & Amortization | 115.50% | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 214.64% | -- | -- | -- | |
| Operating Income | -557.31% | -- | -- | -- | |
| Income Before Tax | -443.80% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -444.54% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -45.74% | -- | -- | -- | |
| EBIT | -557.31% | -- | -- | -- | |
| EBITDA | -701.60% | -- | -- | -- | |
| EPS Basic | 3.36% | -- | -- | -- | |
| Normalized Basic EPS | -194.88% | -- | -- | -- | |
| EPS Diluted | 41.44% | -- | -- | -- | |
| Normalized Diluted EPS | -194.88% | -- | -- | -- | |
| Average Basic Shares Outstanding | 98.69% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 98.69% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |